Quick Takeaways
- This page summarizes Eric K. Rowinsky's Form 4 filing for Fortress Biotech, Inc. (FBIO).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 29 Apr 2022, 16:16.
Eric K. Rowinsky - 01 Jan 2022 Form 4 Insider Report for Fortress Biotech, Inc. (FBIO)
- Role
- Director
- Signature
- /s/ Samuel Berry, Attorney-in-Fact
- Issuer symbol
- FBIO
- Transactions as of
- 01 Jan 2022
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 29 Apr 2022, 16:16:50 UTC
- Previous filing
- 02 Jul 2021
- Next filing
- 20 Dec 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"Eric K. Rowinsky filed Form 4 for Fortress Biotech, Inc. (FBIO) on 29 Apr 2022."
What Changed
- Previous filing in this sequence was filed on 02 Jul 2021.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FBIO | Common Stock, par value $0.001 | Award | $0 | +100,000 | +14% | $0.000000 | 820,000 | 01 Jan 2022 | Direct | F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | One-third of the shares will vest on each January 1, 2023, 2024 and 2025, subject to continued service. |
| F2 | The total holdings include 100,000 shares of deferred restricted stock. |